PD-L1, a known PD-1 receptor, can be expressed in normal cells when combined with PD-1 in immune cells to circumvent the killing of immune cells, thus effectively preventing autoimmune diseases, and is expressed in cancer cells to induce immunosuppression and thereby promote immune escape. Here, CD274 is linked to cancer.